Genetic architecture of NAFLD: where do we stand?
Genome-wide association studies have uncovered robust and reproducible associations between several genetic variations and the natural history of NAFLD. During this webinar, Professor Eric Trépo reviewed these findings that have provided compelling new insights into the biology of NAFLD and highlighted potentially attractive pharmaceutical targets. Professor Eric Trépo also discussed potential applications and limitations of genetic variations for risk prediction in this disease
Speaker: Prof. Eric Trépo
Host: Prof. Manuel Castro Cabezas
Co-host: Prof. Christophe Moreno
Related webinars
Webinar – Time to event trial designs in ALS: How useful are they?
On NOVEMBER 26th, 2024, we organised the webinar: Time to event trial designs in ALS: How useful are they? During this webinar, our speakers Ruben van Eijk, Lotte Smets, Jordi van Unnik and host Lieza Exalto explored the following topics:A...
Webinar – Revolutionizing Kidney Failure Treatment: Clinical Impact and Lessons Learned from the CONVINCE Clinical Trial
On December 12th, we organised the webinar:Revolutionizing Kidney Failure Treatment: Clinical Impact and Lessons Learned from the CONVINCE Clinical TrialDuring this webinar, our speaker and hosts explored the following topics:Study d...
Webinar: Lifestyle Interventions in NAFLD/NASH
On the 19th of September, we presented the 9th webinar of our NASH Webinar Series. During this webinar, speaker Professor Zelber-Sagi explored the relationship between diet and NAFLD, emphasizing that diet not only causes NAFLD but can also serve ...